Skip to content
10-K

Annual Report

Endo, Inc.

0002008861-25-000007

← back to feed
Filed
Mar 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 4, 2025 76.21M sh
Shares Diluted FY 2024 · Dec 31, 2024 76.16M sh
Capex FY 2024 · Dec 31, 2024 $36.99M
Operating Cash Flow FY 2024 · Dec 31, 2024 $113.42M
Long Term Debt FY 2024 · Dec 31, 2024 $2.42B
Long Term Debt FY 2024 · Apr 23, 2024 $2.43B
Short Term Debt FY 2024 · Dec 31, 2024 $15M
Short Term Debt FY 2024 · Apr 23, 2024 $7.5M
Cash And Equivalents FY 2024 · Dec 31, 2024 $387.25M
Cash And Equivalents FY 2024 · Apr 23, 2024 $220.61M
Stockholders Equity FY 2024 · Dec 31, 2024 $1.25B
Stockholders Equity FY 2024 · Apr 23, 2024 $1.98B
Stockholders Equity FY 2024 · Dec 31, 2023 $0
Current Liabilities FY 2024 · Dec 31, 2024 $514.99M
Current Liabilities FY 2024 · Apr 23, 2024 $518.23M
Current Assets FY 2024 · Dec 31, 2024 $1.48B
Current Assets FY 2024 · Apr 23, 2024 $1.76B
Total Assets FY 2024 · Dec 31, 2024 $4.35B
Total Assets FY 2024 · Apr 23, 2024 $5.09B
Eps Diluted FY 2024 · Dec 31, 2024 −$9.60
Eps Basic FY 2024 · Dec 31, 2024 −$9.60
Sga Expense FY 2024 · Dec 31, 2024 $382.63M
Net Income FY 2024 · Dec 31, 2024 −$730.86M
Cost Of Revenue FY 2024 · Dec 31, 2024 $1.18B
Revenue FY 2024 · Dec 31, 2024 $1.18B